Introduction. The study of dialysis patients not needing erythropoiesis-stimulating agents (ESA) for long periods of time has gained interest lately. The aim of this study was to compare laboratory and clinical parameters in hemodialysis patients with autosomal dominant polycystic kidney disease (ADPKD) treated or not with ESA. https://www.ngetikin.com/flash-choice-1-Gallon-Roll-Cote-High-Performance-Moisture-Vapor-Barrier-Coating-and-Primer-limited-super/